30個國家體外診斷（IVD）市場（2026年）7月更新版

Kalorama Information發布的30個國家體外診斷（IVD）市場（2026年）報告對包括美國、中國、德國、英國、沙烏地阿拉伯、英國、日本、法國、越南和土耳其在內的30個主要國家的體外診斷（IVD）市場進行了全面分析。這份詳盡的報告提供了未來五年的市場規模估算和預測，並追蹤了這30個國家的18個IVD細分市場，為讀者提供了對瞬息萬變的全球IVD行業市場格局的及時洞察。

全面細分市場涵蓋

憑藉20 多年的市場研究經驗，Kalorama Information 採用針對特定國家/地區的方法，為以下關鍵 IVD 細分市場提供詳細的估算：

• 血庫篩檢 - 免疫檢測
• 普通化學檢測和急診醫學（核心實驗室）
• 血液學和血液凝固檢驗（PT/INR）
• 組織學
• 免疫檢測- 微生物學
• 免疫檢測 - 非微生物學
• 微生物學 -感染疾病/抗菌藥物敏感性試驗
• 分子診斷（血流感染、院內感染）
• 分子診斷（愛滋病和肝炎）
• 分子診斷（呼吸系統）
• 分子診斷 - 其他
• POC重症監護
• 即時大便潛血試驗
• 即時血糖檢測
• POC感染疾病（全部）
• 即時妊娠及不孕症檢測
• 其他POC
• 其他體外診斷醫療器材

市場促進因素和趨勢

體外診斷（IVD）市場正進入更穩定的擴張階段，成長重點從常規檢測數量轉向高附加價值技術，這些技術能夠提供更高的準確性、更快的檢測速度和更強的臨床效用。本報告分析了這一轉變背後的關鍵促進因素，並涵蓋了市場趨勢和各國具體發展情況，例如波蘭、荷蘭、瑞士和羅馬尼亞等市場在2025年將保持強勁成長，以及俄羅斯在地緣政治動盪和製裁下持續面臨的挑戰。

新增國家附錄

本版新增附錄以細分市場結構呈現了Kalorama Information的市場估算和預測，為本報告涵蓋的18個體外診斷（IVD）細分市場提供了跨國觀點。每個標籤頁對應一個細分市場，每行代表30個市場，每列分別顯示2025年的預估收入、2030年的預測收入以及2025年至2030年的CAGR。 總行匯總了所有30個市場的資料，計算涵蓋所有國家的細分市場層面的CAGR。基礎資料與各國特定表格中的資料相同，但為了方便讀者比較不同地區而非依市場章節分類的細分市場表現，資料結構進行了重新調整。

獨特且權威的資訊來源

與分散的國別報告不同，Kalorama 的30個國家體外診斷（IVD）市場（2026年）將這些洞察整合到一個權威的單一資訊來源中，這與公司提供全面且可操作的市場情報的使命相契合。本報告將於2026年發布兩次，第一版於 7月發布，第二版於第四季發布。購買者可同時獲得兩個版本，確保始終掌握最新資料，在瞬息萬變的全球體外診斷市場中做出策略決策。

目錄

第1章 全球體外診斷市場

Kalorama相關消息

體外診斷市場的需求與成長

研究範圍和調查方法

市場區隔

• 血庫篩檢 - 免疫檢測
• 血液凝固檢驗- PT/INR
• 加護病房（中心檢查室）
• 普通化學
• 血液學
• 組織學
• 免疫檢測- 微生物學
• 免疫檢測 - 非微生物學
• 分子生物學檢測 - 血流感染疾病/醫療相關感染疾病
• 分子生物學檢測 - 愛滋病毒和肝炎
• 微生物學 - 鑑定/抗生素敏感性試驗
• 分子 - 呼吸作用
• 照護現場偵測（POC）
  • 床邊重症加護
  • 即時大便潛血試驗
  • POC血糖檢測（所有項目）
  • 感染疾病（所有疾病）
  • POC妊娠及不孕症治療

國家地圖區域

主要國家的銷售額

第2章 美國

美國體外診斷市場概覽

消息

第3章 德國

德國體外診斷市場概覽

消息

第4章 中國

中國體外診斷市場概覽

消息

第5章 日本

日本體外診斷市場概覽

消息

第6章 法國

法國體外診斷市場概覽

消息

第7章 英國

英國體外診斷市場概覽

消息

第8章 義大利

義大利體外診斷市場概覽

消息

第9章 加拿大

加拿大體外診斷市場概覽

消息

第10章 西班牙

西班牙體外診斷市場概覽

第11章 澳洲

澳洲體外診斷市場概覽

第12章 巴西

巴西體外診斷市場概覽

消息

第13章 印度

印度體外診斷市場概覽

消息

第14章 俄羅斯

俄羅斯體外診斷市場概覽

第15章 荷蘭

荷蘭體外診斷市場概覽

消息

第16章 瑞士

瑞士體外診斷市場概覽

第17章 土耳其

土耳其體外診斷市場概覽

第18章 波蘭

波蘭體外診斷市場概覽

消息

第19章 墨西哥

墨西哥體外診斷市場概覽

第20章 瑞典

瑞典體外診斷市場概覽

消息

第21章 比利時

比利時體外診斷市場概覽

第22章 奧地利

奧地利體外診斷市場概覽

第23章 沙烏地阿拉伯

沙烏地阿拉伯體外診斷市場概覽

第24章 韓國

韓國體外診斷市場概覽

消息

第25章 埃及

埃及體外診斷市場概覽

第26章 羅馬尼亞

羅馬尼亞體外診斷市場概覽

消息

第27章 南非

南非體外診斷市場概覽

第28章 印尼

印尼體外診斷市場概覽

第29章 智利

智利體外診斷市場概覽

消息

第30章 阿拉伯聯合大公國

阿拉伯聯合大公國體外診斷市場概覽

消息

第31章 越南

越南體外診斷市場概覽

消息

附錄：前30大國家體外診斷（IVD）市場銷售（2025-2030年）

附錄概要

血庫篩檢- 免疫學

普通化學和重症監護

血液學和凝血

組織學

免疫檢測- 微生物學

免疫檢測 - 非微生物學

微生物學鑑定-藥敏試驗

分子血流-HAI

分子層面的愛滋病毒和肝炎

分子呼吸

分子 - 其他

照護現場重症加護

照護現場（POC）大便潛血試驗

照護現場（所有類型）

照護現場（POC）感染疾病

妊娠和不孕症治療中的照護現場（POC）

其他體外診斷試劑

其他照護現場（POC）

Kalorama Information's 30-Country IVD Market Atlas, 2026 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the United States, China, Germany, United Kingdom, Saudi Arabia, India, Japan, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing and forecasts spanning five years, tracking 18 IVD segments across all 30 markets to provide timely insights into the evolving global IVD landscape.

Comprehensive Segment Coverage

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

• Blood Bank Screening – Immunoassays
• General Chemistry and Critical Care (Core Laboratory)
• Hematology and Coagulation PT/INR
• Histology
• Immunoassays – Microbiology
• Immunoassays – Non-Microbiology
• Microbiology – ID/AST
• Molecular Bloodstream/HAI
• Molecular HIV & Hepatitis
• Molecular Respiratory
• Molecular - Other
• POC Critical Care
• POC Fecal Occult Blood Testing
• POC Glucose
• POC Infectious Disease (All)
• POC Pregnancy & Fertility
• Other POC
• Other IVD

Market Drivers and Trends

The IVD market is entering a period of more stable expansion, with growth shifting away from routine test volume toward higher-value technologies that offer improved accuracy, faster results, and stronger clinical utility. The report examines the key drivers behind this transition. The report also captures market-shaping developments and country-level dynamics—from stronger 2025 performance in markets like Poland, the Netherlands, Switzerland, and Romania, to the ongoing challenges facing Russia amid geopolitical disruption and sanctions.

New Cross-Country Appendix

New to this edition, an appendix presents Kalorama Information's market estimates in a segment-by-segment structure, offering a cross-country view of each of the 18 IVD segments covered in the report. Each tab corresponds to one segment, with rows representing the 30 markets and columns showing 2025 estimated revenue, 2030 projected revenue, and the 2025–2030 CAGR. A total row aggregates all 30 markets and derives the implied segment-level CAGR across the full country set. The underlying data is identical to that found in the individual country tables, recontextualized for readers comparing segment performance across geographies rather than across market chapters.

A Single, Authoritative Resource

Unlike fragmented country-specific reports, Kalorama's 30-Country IVD Market Atlas, 2026 consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence. The report will be published twice in 2026, with the first edition released in July and a second following in Q4; buyers receive access to both editions with purchase, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.

Table of Contents

CHAPTER ONE: WORLDWIDE IVD MARKET

ABOUT KALORAMA INFORMATION

IVD MARKET DEMAND AND GROWTH

SCOPE AND METHODOLOGY

MARKET SEGMENTATION

• Blood Bank Screening – Immunoassays
• Coagulation – PT/INR
• Critical Care (Core Laboratory)
• General Chemistry
• Hematology
• Histology
• Immunoassays – Microbiology
• Immunoassays – Non-Microbiology
• Molecular – Bloodstream/HAI
• Molecular – HIV and Hepatitis
• Microbiology - ID/AST
• Molecular – Respiratory
• Point-of-Care (POC) Testing
  • POC Critical Care
  • POC Fecal Occult
  • POC Glucose (All)
  • POC Infectious Disease (All)
  • POC Pregnancy and Fertility

COUNTRY ATLAS SCOPE

• Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2025

LEADING COUNTRY REVENUES

• Table 1-2: Global IVD Market by Leading Countries, Estimated 2025-2030 (US$ million)
• Figure 1-1: Leading Global IVD Market #1-#15 Comparison, Estimated 2025-2030 (US$ million)
• Figure 1-2: Second-Tier Leading Global IVD Market #16-#30 Comparison, Estimated 2025-2030 (US$ million)

CHAPTER TWO: UNITED STATES

UNITED STATES IVD MARKET OVERVIEW

• Table 2-1: United States IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 2-1: United States IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER THREE: GERMANY

GERMANY IVD MARKET OVERVIEW

• Table 3-1: Germany IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 3-1: Germany IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER FOUR: CHINA

CHINA IVD MARKET OVERVIEW

• Table 4-1: China IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 4-1: China IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER FIVE: JAPAN

JAPAN IVD MARKET OVERVIEW

• Table 5-1: Japan IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 5-1: Japan IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER SIX: FRANCE

FRANCE IVD MARKET OVERVIEW

• Table 6-1: France IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 6-1: France IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER SEVEN: UNITED KINGDOM

UNITED KINGDOM IVD MARKET OVERVIEW

• Table 7-1: United Kingdom IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 7-1: United Kingdom IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER EIGHT: ITALY

ITALY IVD MARKET OVERVIEW

• Table 8-1: Italy IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 8-1: Italy IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER NINE: CANADA

CANADA IVD MARKET OVERVIEW

• Table 9-1: Canada IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 9-1: Canada IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER TEN: SPAIN

SPAIN IVD MARKET OVERVIEW

• Table 10-1: Spain IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 10-1: Spain IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER ELEVEN: AUSTRALIA

AUSTRALIA IVD MARKET OVERVIEW

• Table 11-1: Australia IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 11-1: Australia IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWELVE: BRAZIL

BRAZIL IVD MARKET OVERVIEW

• Table 12-1: Brazil IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 12-1: Brazil IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER THIRTEEN: INDIA

INDIA IVD MARKET OVERVIEW

• Table 13-1: India IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 13-1: India IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER FOURTEEN: RUSSIA

RUSSIA IVD MARKET OVERVIEW

• Table 14-1: Russia IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 14-1: Russia IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER FIFTEEN: THE NETHERLANDS

THE NETHERLANDS IVD MARKET OVERVIEW

• Table 15-1: The Netherlands IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 15-1: The Netherlands IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER SIXTEEN: SWITZERLAND

SWITZERLAND IVD MARKET OVERVIEW

• Table 16-1: Switzerland IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 16-1: Switzerland IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER SEVENTEEN: TURKEY

TURKEY IVD MARKET OVERVIEW

• Table 17-1: Turkey IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 17-1: Turkey IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER EIGHTEEN: POLAND

POLAND IVD MARKET OVERVIEW

• Table 18-1: Poland IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 18-1: Poland IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER NINETEEN: MEXICO

MEXICO IVD MARKET OVERVIEW

• Table 19-1: Mexico IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 19-1: Mexico IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY: SWEDEN

SWEDEN IVD MARKET OVERVIEW

• Table 20-1: Sweden IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 20-1: Sweden IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER TWENTY-ONE: BELGIUM

BELGIUM IVD MARKET OVERVIEW

• Table 21-1: Belgium IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 21-1: Belgium IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY-TWO: AUSTRIA

AUSTRIA IVD MARKET OVERVIEW

• Table 22-1: Austria IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 22-1: Austria IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY-THREE: SAUDI ARABIA

SAUDI ARABIA IVD MARKET OVERVIEW

• Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 23-1: Saudi Arabia IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY-FOUR: SOUTH KOREA

SOUTH KOREA IVD MARKET OVERVIEW

• Table 24-1: South Korea IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 24-1: South Korea IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER TWENTY-FIVE: EGYPT

EGYPT IVD MARKET OVERVIEW

• Table 25-1: Egypt IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 25-1: Egypt IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY-SIX: ROMANIA

ROMANIA IVD MARKET OVERVIEW

• Table 26-1: Romania IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 26-1: Romania IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER TWENTY-SEVEN: SOUTH AFRICA

SOUTH AFRICA IVD MARKET OVERVIEW

• Table 27-1: South Africa IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 27-1: South Africa IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY-EIGHT: INDONESIA

INDONESIA IVD MARKET OVERVIEW

• Table 28-1: Indonesia IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 28-1: Indonesia IVD Market by Segment, Estimated 2025-2030 (US$ million)

CHAPTER TWENTY-NINE: CHILE

CHILE IVD MARKET OVERVIEW

• Table 29-1: Chile IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 29-1: Chile IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER THIRTY: UNITED ARAB EMIRATES

UNITED ARAB EMIRATES IVD OVERVIEW

• Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 30-1: United Arab Emirates IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

CHAPTER THIRTY-ONE: VIETNAM

VIETNAM IVD MARKET OVERVIEW

• Table 31-1: Vietnam IVD Market by Segment, Estimated 2025-2030 (US$ million)
• Figure 31-1: Vietnam IVD Market by Segment, Estimated 2025-2030 (US$ million)

News

APPENDIX: IVD SEGMENT REVENUES BY TOP 30 COUNTRIES, 2025–2030

APPENDIX OVERVIEW

BLOOD BANK SCREENING - IMMUNOS

• Table A1: Blood Bank Screening – Immunos Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

GENERAL CHEMISTRIES AND CRITICAL CARE

• Table A2: General Chemistries and Critical Care Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

HEMATOLOGY AND COAGULATION

• Table A3: Hematology and Coagulation, by Top 30 Countries, Estimated 2025-2030 (US$ million)

HISTOLOGY

• Table A4: Histology, by Top 30 Countries, Estimated 2025-2030 (US$ million)

IMMUNOASSAYS – MICROBIOLOGY

• Table A5: Immunoassays – Microbiology Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

IMMUNOASSAYS – NON-MICROBIOLOGY

• Table A6: Immunoassays – Non-Microbiology Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

MICROBIOLOGY - ID-AST

• Table A7: Microbiology - ID-AST Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

MOLECULAR BLOODSTREAM-HAI

• Table A8: Molecular Bloodstream-HAI Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

MOLECULAR HIV AND HEPATITIS

• Table A9: Molecular HIV and Hepatitis Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

MOLECULAR RESPIRATORY

• Table A10: Molecular Respiratory Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

MOLECULAR – OTHER

• Table A11: Molecular – Other Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

POINT-OF-CARE (POC) CRITICAL CARE

• Table A12: POC Critical Care Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

POINT-OF-CARE (POC) FECAL OCCULT

• Table A13: POC Fecal Occult Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

POINT-OF-CARE (POC) GLUCOSE (ALL)

• Table A14: POC Glucose (All) Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

POINT-OF-CARE (POC) INFECTIOUS DISEASE

• Table A15: POC Infectious Disease Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

POINT-OF-CARE (POC) PREGNANCY AND FERTILITY

• Table A16: POC Pregnancy and Fertility Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

OTHER IVD

• Table A17: Other IVD Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)

OTHER POINT-OF-CARE (POC)

• Table A18: Other Point-of-Care Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)